Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial
腹腔内注射伊立替康联合FOLFOX方案和贝伐单抗治疗不可切除的结直肠癌腹膜转移患者:多中心、开放标签、II期INTERACT-II试验方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-077667
van de Vlasakker, Vincent C J; Guchelaar, Niels A D; van den Heuvel, Teun B M; Lurvink, Robin J; van Meerten, Esther; Bax, Ramon J F; Creemers, Geert-Jan M; van Hellemond, Irene E G; Brandt-Kerkhof, Alexandra R M; Madsen, Eva V E; Nederend, Joost; Koolen, Stijn L W; Nienhuijs, Simon W; Kranenburg, Onno; de Hingh, Ignace H J T; Verhoef, Cornelis; Mathijssen, Ron H J; Burger, Jacobus W A